Data updated: Mar 10, 2026
MOMETASONE FUROATE
MOMETASONE FUROATE
Approved 2002-03-18
23
Indications
--
Phase 3 Trials
23
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2002-03-18
- Routes
- TOPICAL, NASAL
- Dosage Forms
- LOTION, CREAM, OINTMENT, SPRAY, METERED
Companies
SUN PHARMA CANADA FOUGERA PHARMS ENCUBE COSETTE NASPRESS GLENMARK PHARMS LTD Aurobindo Pharma AMNEAL PADAGIS US GLENMARK PHARMS INC Apotex AMNEAL PHARMS CHARTWELL MOLECULAR PADAGIS ISRAEL TORRENT
Active Ingredient: MOMETASONE FUROATE
Website: ↗
MOMETASONE FUROATE Approval History
Loading approval history...
What MOMETASONE FUROATE Treats
23 FDA approvalsOriginally approved for its first indication in 2002 . Covers 23 distinct patient populations.
- Other (23)
Other
(23 approvals)- • Approved indication (Mar 2002)Label Letter
- • Approved indication (Nov 2003)
- • Approved indication (Dec 2004)
- • Approved indication (Dec 2004)Letter
- • Approved indication (Mar 2005)
- • Approved indication (Apr 2005)
- • Approved indication (Apr 2005)
- • Approved indication (Mar 2006)
- • Approved indication (May 2006)
- • Approved indication (Jun 2006)
- • Approved indication (Apr 2007)
- • Approved indication (Nov 2007)
- • Approved indication (Nov 2007)
- • Approved indication (May 2008)
- • Approved indication (Aug 2010)
- • Approved indication (Mar 2016)Letter
- • Approved indication (Apr 2017)
- • Approved indication (Jul 2018)
- • Approved indication (Jun 2023)
- • Approved indication (Mar 2024)
- • Approved indication (Apr 2024)
- • Approved indication (Nov 2024)
- • Approved indication (May 2025) New
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MOMETASONE FUROATE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.